| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | recombination hotspot binding | 1.11e-05 | 2 | 67 | 2 | GO:0010844 | |
| GeneOntologyBiologicalProcess | positive regulation of reciprocal meiotic recombination | 6.21e-05 | 4 | 67 | 2 | GO:0010845 | |
| GeneOntologyBiologicalProcess | regulation of reciprocal meiotic recombination | 6.21e-05 | 4 | 67 | 2 | GO:0010520 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 8.58e-05 | 324 | 67 | 7 | GO:0006302 | |
| GeneOntologyBiologicalProcess | meiosis I | 1.16e-04 | 147 | 67 | 5 | GO:0007127 | |
| GeneOntologyBiologicalProcess | homologous chromosome segregation | 1.21e-04 | 78 | 67 | 4 | GO:0045143 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 1.29e-04 | 240 | 67 | 6 | GO:0140013 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle process | 1.49e-04 | 155 | 67 | 5 | GO:0061982 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 2.34e-04 | 268 | 67 | 6 | GO:1903046 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 2.35e-04 | 37 | 67 | 3 | GO:0051446 | |
| MousePheno | abnormal female meiosis I arrest | 1.35e-05 | 13 | 52 | 3 | MP:0010767 | |
| Domain | SSXRD | 3.19e-04 | 8 | 64 | 2 | PF09514 | |
| Domain | SSXRD_motif | 3.19e-04 | 8 | 64 | 2 | IPR019041 | |
| Domain | KRAB_RELATED | 6.23e-04 | 11 | 64 | 2 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 8.80e-04 | 13 | 64 | 2 | IPR003655 | |
| Domain | PAS_fold_3 | 2.79e-03 | 23 | 64 | 2 | IPR013655 | |
| Domain | PAS_3 | 2.79e-03 | 23 | 64 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 3.04e-03 | 24 | 64 | 2 | IPR000700 | |
| Domain | PAC | 3.56e-03 | 26 | 64 | 2 | IPR001610 | |
| Domain | PAC | 3.56e-03 | 26 | 64 | 2 | SM00086 | |
| Domain | PAC | 3.56e-03 | 26 | 64 | 2 | PS50113 | |
| Domain | ACR | 3.84e-03 | 27 | 64 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 3.84e-03 | 27 | 64 | 2 | IPR006586 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TRIM33 TBC1D4 SERPINB3 FOS PER1 POGZ REV3L SNRNP200 MTPAP GATAD2B | 5.46e-06 | 857 | 67 | 10 | 25609649 |
| Pubmed | Circadian genes and risk of prostate cancer: Findings from the EPICAP study. | 1.10e-05 | 3 | 67 | 2 | 30665264 | |
| Pubmed | Hippocampal gene expression induced by cold swim stress depends on sex and handling. | 1.10e-05 | 3 | 67 | 2 | 25459888 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 17264841 | ||
| Pubmed | Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. | 2.19e-05 | 4 | 67 | 2 | 21285412 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 19829696 | ||
| Pubmed | Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. | 2.19e-05 | 4 | 67 | 2 | 18231586 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 18425216 | ||
| Pubmed | USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. | 3.64e-05 | 5 | 67 | 2 | 24493797 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 18990770 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 18316400 | ||
| Pubmed | Variants in circadian genes and prostate cancer risk: a population-based study in China. | 3.64e-05 | 5 | 67 | 2 | 17984998 | |
| Pubmed | The molecular clock mediates leptin-regulated bone formation. | 5.46e-05 | 6 | 67 | 2 | 16143109 | |
| Pubmed | The trophoblast clock controls transport across placenta in mice. | 7.63e-05 | 7 | 67 | 2 | 33913482 | |
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 10668202 | ||
| Pubmed | Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. | 7.63e-05 | 7 | 67 | 2 | 22936566 | |
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 14675547 | ||
| Pubmed | A genome-wide association study of hypertension and blood pressure in African Americans. | 1.02e-04 | 8 | 67 | 2 | 19609347 | |
| Pubmed | 1.30e-04 | 9 | 67 | 2 | 21917142 | ||
| Pubmed | Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. | 1.63e-04 | 10 | 67 | 2 | 16528748 | |
| Pubmed | Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. | 1.63e-04 | 10 | 67 | 2 | 19934327 | |
| Pubmed | 2.17e-04 | 152 | 67 | 4 | 34299191 | ||
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 2.38e-04 | 12 | 67 | 2 | 14645221 | |
| Pubmed | 4.02e-04 | 74 | 67 | 3 | 26332085 | ||
| Pubmed | Early life environment, neurodevelopment and the interrelation with atopy. | 4.31e-04 | 16 | 67 | 2 | 20701904 | |
| Pubmed | PER2 variantion is associated with depression vulnerability. | 4.31e-04 | 16 | 67 | 2 | 19693801 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 5.37e-04 | 344 | 67 | 5 | 30333137 | |
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 15741322 | ||
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 20174623 | ||
| Pubmed | 6.12e-04 | 19 | 67 | 2 | 20072116 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 6.35e-04 | 357 | 67 | 5 | 37059091 | |
| Pubmed | 7.50e-04 | 21 | 67 | 2 | 19839995 | ||
| Pubmed | 9.01e-04 | 23 | 67 | 2 | 16638864 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 9.44e-04 | 1321 | 67 | 9 | 27173435 | |
| Pubmed | 1.07e-03 | 25 | 67 | 2 | 36067211 | ||
| Pubmed | 1.08e-03 | 233 | 67 | 4 | 37704626 | ||
| Pubmed | Replication of genetic association studies in asthma and related phenotypes. | 1.15e-03 | 26 | 67 | 2 | 20395963 | |
| Pubmed | 1.15e-03 | 26 | 67 | 2 | 23435420 | ||
| Pubmed | Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. | 1.34e-03 | 28 | 67 | 2 | 19661089 | |
| Pubmed | 1.44e-03 | 29 | 67 | 2 | 14563677 | ||
| Pubmed | 1.91e-03 | 272 | 67 | 4 | 31010829 | ||
| Cytoband | 14q32.3 | 9.37e-05 | 10 | 67 | 2 | 14q32.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 1.06e-03 | 136 | 67 | 3 | chr16q24 | |
| Cytoband | 16q24.3 | 2.65e-03 | 52 | 67 | 2 | 16q24.3 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 6.36e-04 | 17 | 40 | 2 | 1197 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 1.14e-05 | 200 | 66 | 6 | M9484 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN | 1.14e-05 | 200 | 66 | 6 | M5204 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 2.92e-05 | 400 | 65 | 8 | GSM538242_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 3.67e-05 | 413 | 65 | 8 | GSM538263_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.54e-04 | 88 | 65 | 4 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k2_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1 | 1.67e-04 | 383 | 65 | 7 | GSM605826_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3 | 1.89e-04 | 391 | 65 | 7 | GSM538249_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2 | 2.27e-04 | 403 | 65 | 7 | GSM605834_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1 | 2.41e-04 | 407 | 65 | 7 | GSM854287_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 2.41e-04 | 407 | 65 | 7 | GSM538245_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1 | 2.60e-04 | 412 | 65 | 7 | GSM605839_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | 2.84e-04 | 418 | 65 | 7 | GSM605836_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 2.88e-04 | 419 | 65 | 7 | GSM854285_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 3.14e-04 | 425 | 65 | 7 | GSM538255_500 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-07 | 181 | 67 | 6 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 4.06e-06 | 158 | 67 | 5 | 7098847804dd90fa1dd74536e4e90f989b630fe4 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.14e-06 | 172 | 67 | 5 | 4b1d4920f121d063784133969a797c05eb7feaa2 | |
| ToppCell | VE-mDC1-|VE / Condition, Cell_class and T cell subcluster | 1.07e-05 | 193 | 67 | 5 | 5df6033bc0e4f96a20d526486a8e89c990e21831 | |
| ToppCell | VE-mDC1|VE / Condition, Cell_class and T cell subcluster | 1.07e-05 | 193 | 67 | 5 | 12b2708db9db8b88365b8ebeb4908f28c50081bb | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.21e-05 | 198 | 67 | 5 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | COVID-19-Myeloid-MoAM3,_VCAN|COVID-19 / Condition, Lineage and Cell class | 1.24e-05 | 199 | 67 | 5 | aba0b833e44fe42625fac91466f6ebaa8e786d3b | |
| ToppCell | COVID-19-Myeloid-MoAM3,_VCAN|Myeloid / Condition, Lineage and Cell class | 1.24e-05 | 199 | 67 | 5 | 80f70c53e892fb692ef655662732e16e2c03ac8e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 200 | 67 | 5 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.91e-05 | 140 | 67 | 4 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.14e-05 | 147 | 67 | 4 | a82a971a934faff6806823ca62a398b429ecd9c8 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 164 | 67 | 4 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 165 | 67 | 4 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 165 | 67 | 4 | 83095377aedf960c05baa523869bdbd2b0a05f2d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-04 | 165 | 67 | 4 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 166 | 67 | 4 | 75d719617c61409860f298ce91cbe3a0aafa0553 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 170 | 67 | 4 | b535baeb4dbd644051cf992babb61add9eaae4e3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 170 | 67 | 4 | 2477c9f29dbe27f172df699003971e828d6ab8c9 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 171 | 67 | 4 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.28e-04 | 171 | 67 | 4 | ce290930385cac35dbd21a5e91cf0f93cf3e99f8 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-04 | 173 | 67 | 4 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-04 | 173 | 67 | 4 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 173 | 67 | 4 | 94f99f7e7813d6e53e0bedf97087400b1bf00129 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.37e-04 | 174 | 67 | 4 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | Adult-Immune-dendritic_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.43e-04 | 176 | 67 | 4 | 1f0f1f953e6d61119f342de0d980aa1287511dba | |
| ToppCell | PBMC-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters | 1.46e-04 | 177 | 67 | 4 | 974305e4c0eff90134c4e58cf11b955d1eee0501 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 67 | 4 | a0ff337f11bdb11959ac71805ff94be6b4ec1083 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 1.46e-04 | 177 | 67 | 4 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | Pericytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.49e-04 | 178 | 67 | 4 | a2448d868da2abe48c394c51264aad03e866dfec | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.49e-04 | 178 | 67 | 4 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.53e-04 | 179 | 67 | 4 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-04 | 181 | 67 | 4 | 57f20341c3e9f9f6ed5b6c181605ad35bae91414 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.59e-04 | 181 | 67 | 4 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-04 | 181 | 67 | 4 | 6df40f86c569b6ecfc3137a68d1355b012dbf6bf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.63e-04 | 182 | 67 | 4 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Pericytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.66e-04 | 183 | 67 | 4 | 4617b18da8d699a44e4c47980197b1e7eb951470 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Immature_B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 184 | 67 | 4 | e6669a1b7ea7e4f8e094add5117689470019d85d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 185 | 67 | 4 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-04 | 185 | 67 | 4 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 185 | 67 | 4 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 186 | 67 | 4 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 1.77e-04 | 186 | 67 | 4 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.81e-04 | 187 | 67 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-04 | 187 | 67 | 4 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.84e-04 | 188 | 67 | 4 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Immature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 189 | 67 | 4 | 5776f842b3047d21ccdc44db884bfd210823c7da | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 190 | 67 | 4 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 190 | 67 | 4 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 190 | 67 | 4 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 190 | 67 | 4 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-04 | 190 | 67 | 4 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | Severe-B_activate-7|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.92e-04 | 190 | 67 | 4 | 67e6c8a5a8724bdf2861fd76a711319dfc71d47a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-04 | 190 | 67 | 4 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.96e-04 | 191 | 67 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 192 | 67 | 4 | d44f46352bac414b45cc749f7cbdc3a159bd7ae8 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 192 | 67 | 4 | aa65557b35d3eba9f24b970849255d05174d1c05 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 192 | 67 | 4 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.04e-04 | 193 | 67 | 4 | b044fca95f519ff2ceb378afe40a95911931a29e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 193 | 67 | 4 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 2.08e-04 | 194 | 67 | 4 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Immature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.08e-04 | 194 | 67 | 4 | f957cec2f309d726e095d18a7da32789dca92a36 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-04 | 194 | 67 | 4 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-04 | 195 | 67 | 4 | 7dd0cb8f3753fe761fac200cbd161708b6528c51 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 195 | 67 | 4 | d8d2467196d7b2ce0c2cf6782e03e6db141ed3bf | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 195 | 67 | 4 | 391d8e00dd5f988baa6dbda8414d3c020679ea2f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 195 | 67 | 4 | 68b579258caf023570c3922269e831e27d847934 | |
| ToppCell | (000)_CD14+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 2.20e-04 | 197 | 67 | 4 | cff498bc7b153f28dd013eaeb73ead4fb62fb44c | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 197 | 67 | 4 | 311438418f3d697e54222da111014c887fd815f5 | |
| ToppCell | distal-2-Hematologic-Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.20e-04 | 197 | 67 | 4 | 9a1c9221904ad1e46e64e3785516804e87128adc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 197 | 67 | 4 | c34d0d11c5c6154988b41e00aea169090cb09785 | |
| ToppCell | distal-Hematologic-Classical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.20e-04 | 197 | 67 | 4 | 9f4b0857012cd503e668bac115010216a946f73c | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-04 | 197 | 67 | 4 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.25e-04 | 198 | 67 | 4 | c58e2d3a21fcca9f1accccc5303ca4222b6c8432 | |
| ToppCell | (00)_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 2.25e-04 | 198 | 67 | 4 | 2252e756a8a25d32c16a723e833c1390a772c2a4 | |
| ToppCell | Int-URO-Myeloid|Int-URO / Disease, Lineage and Cell Type | 2.25e-04 | 198 | 67 | 4 | 895ec2ec9f46a96a5d489beded8f05ca5b860a8d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 198 | 67 | 4 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.25e-04 | 198 | 67 | 4 | 9c17589ef0f6583c4c106c06936877fd74c258ce | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 198 | 67 | 4 | c00dbe61dc25602f19bd42a760646680002961ca | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.25e-04 | 198 | 67 | 4 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | URO-Myeloid|URO / Disease, Lineage and Cell Type | 2.25e-04 | 198 | 67 | 4 | 65a8879da871ddebeda945f312ea7c1065732040 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.25e-04 | 198 | 67 | 4 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.25e-04 | 198 | 67 | 4 | feac39036b5c0ab97b524cc366286942d136d42f | |
| ToppCell | NS-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-04 | 198 | 67 | 4 | 58f2bc88d92550fb0b7c2e46c63c49ec6777001c | |
| ToppCell | NS-critical-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-04 | 198 | 67 | 4 | fd5dd6d6d72356d4eac8637350405c69ccb7161c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.25e-04 | 198 | 67 | 4 | f4ff9520598ebc52b3a1f31eee766957983e16b4 | |
| ToppCell | NS-critical-d_16-33-Myeloid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.25e-04 | 198 | 67 | 4 | 5602a78068ab6cccd4da1cc5566e68805820a295 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.29e-04 | 199 | 67 | 4 | 30523cf08815ca214877e33a2c52197ff8318557 | |
| ToppCell | IIF-Myeloid-CD14_Mono|IIF / Disease, Lineage and Cell Type | 2.29e-04 | 199 | 67 | 4 | accfb3d8ad3f03f9302f2056ca16c1be6231a351 | |
| ToppCell | BAL-Mild-Myeloid-TRAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.29e-04 | 199 | 67 | 4 | 8a31a459491aa8625802c5211d38d57c1e8be76b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.29e-04 | 199 | 67 | 4 | 105709b97c55826a852aed27658e3b4af1738c8a | |
| ToppCell | LPS_only|World / Treatment groups by lineage, cell group, cell type | 2.29e-04 | 199 | 67 | 4 | 852cf595c2255983cff9045f2bb746d4391cf5ba | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-04 | 199 | 67 | 4 | 0892957a49304ce4b6daa3657d76d8365ce0dd19 | |
| ToppCell | BAL-Mild-Myeloid-TRAM|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-04 | 199 | 67 | 4 | 27c63da6b29a1fc57ed2568443ba5029f3cdb186 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-04 | 199 | 67 | 4 | b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-04 | 199 | 67 | 4 | 4e518651ff219e163cfd9deb58566df6308aa3f7 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM3|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.29e-04 | 199 | 67 | 4 | 4ab5da8ab757e8294c743949a5374b6e6a388913 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.29e-04 | 199 | 67 | 4 | af167e7a16c3537ce0aa821f608cdcb0c3abc07f | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.29e-04 | 199 | 67 | 4 | 4b88ce864dc75ed8596a076ce4498f73639bbac8 | |
| ToppCell | IIF-Myeloid|IIF / Disease, Lineage and Cell Type | 2.29e-04 | 199 | 67 | 4 | e27b9dfd671c40c475b46dd0ff3195e1185efe77 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.29e-04 | 199 | 67 | 4 | 961ad44199871be8e09d31904d383edc865ba262 | |
| Disease | rhinitis (is_implicated_in) | 3.97e-05 | 30 | 65 | 3 | DOID:4483 (is_implicated_in) | |
| Disease | Juvenile-Onset Still Disease | 2.29e-04 | 135 | 65 | 4 | C0087031 | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 4.27e-04 | 14 | 65 | 2 | DOID:898 (is_marker_for) | |
| Disease | corneal hysteresis | 8.85e-04 | 20 | 65 | 2 | EFO_0010066 | |
| Disease | methionine measurement | 1.50e-03 | 26 | 65 | 2 | EFO_0009771 | |
| Disease | eye measurement | 1.62e-03 | 27 | 65 | 2 | EFO_0004731 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SCVSSAQPPRIFVAH | 731 | Q14511 | |
| NRSPSPFHAVAECRN | 36 | Q9ULA0 | |
| FGPDFRHCPNTSAQD | 456 | Q9UP79 | |
| EPAPFNKRHCRSFDF | 41 | C9J069 | |
| HHFSDPACRQPTFTV | 316 | Q8NCL9 | |
| RFCSTAAPFIKSHVP | 196 | Q8IYW2 | |
| EFSQRIFCHGAPPFV | 211 | Q4W4Y0 | |
| ATGHPFPRVFSACSR | 376 | Q9BZ11 | |
| PCRHDDVFFPPSASF | 136 | Q9BXJ7 | |
| NCTDPAIHEFPTDLF | 76 | Q8NFF2 | |
| QTVPDCRDPAFHEHF | 191 | P49796 | |
| CRDPAFHEHFFFPVQ | 196 | P49796 | |
| QTCSAHPARFSPDDK | 26 | Q9NPE3 | |
| SVLVDEFCSEFHPNP | 421 | Q8IWA4 | |
| DASQCQPSPDFSHDR | 656 | Q99743 | |
| CFSVFARPSSVPHGA | 31 | Q96CN7 | |
| CPFPSRRSQHTDDSA | 531 | Q96II8 | |
| PEADSFPSCAAAHRK | 346 | P01100 | |
| TPVDDFHTNDVCSFP | 496 | Q9UK73 | |
| HPLTCDDPRFQASSS | 126 | P0DN87 | |
| SAPGDAQFCPRVNHA | 111 | Q9BZM3 | |
| AGQPFDHSPIRFCAR | 416 | O15534 | |
| VNDNAPRFFPSHCAV | 3106 | Q9NYQ8 | |
| PRFFPSHCAVAVFDN | 3111 | Q9NYQ8 | |
| ICQAHFAPISPGFSR | 216 | Q6P3R8 | |
| ECVHRGFPEISFQPS | 136 | P14543 | |
| PRESAEAFHNLHPAC | 346 | Q8IV20 | |
| NQFHATCLDTFPPIS | 261 | P53602 | |
| EPFVCAQCRTDFTPH | 416 | Q8WXI9 | |
| PCPEHSRALENASTF | 301 | Q5JZY3 | |
| PLVRFSHQASGFQCD | 311 | Q9NVV4 | |
| DPIDGTCNFVHRFPT | 101 | O14732 | |
| FFIDSCAAHGPPTFV | 211 | Q9NQV7 | |
| HSPAFSCEQVRAFPA | 181 | P08571 | |
| EVPHFASPTACRAVA | 186 | Q14674 | |
| AHFRNTTCFPAKAVD | 461 | O15229 | |
| CAAFANHSGRPFRPN | 161 | P10635 | |
| PFSVPDFDFLQHCAE | 656 | Q96C10 | |
| FSNCFSRPEQTLPHS | 31 | Q9Y4F3 | |
| ASAPIPFFHRCAPVN | 166 | Q8WWI5 | |
| FGPSHFSVLAFPCNQ | 96 | Q8TED1 | |
| CRAEHLTVPSFAFEP | 2256 | O95180 | |
| SNVIHHFFCDSPPLF | 171 | O95221 | |
| PHTACPANDFANVTE | 426 | A2RUB1 | |
| PAANGAIRFHCDPTF | 451 | Q9UPN9 | |
| NFPKVATSFRCPHCT | 486 | Q7Z3K3 | |
| FFIDSCAAHGPPTFV | 211 | Q9NQW5 | |
| HPDNARTRSCPAFST | 786 | Q9H2Y9 | |
| FFIAPRQSTVDPTHC | 41 | Q9H5K3 | |
| FDPAAAAFSHPQAAQ | 61 | Q01892 | |
| PTSTNEEFHCNHPFL | 356 | P29508 | |
| PIPHNSSSRFDCNSV | 81 | Q13286 | |
| SPCQHFNFSVAPLVD | 136 | Q8N614 | |
| HPDSCEAVNPTRFRA | 271 | Q9UK80 | |
| FPSSRDDLHPSVVCN | 1311 | O60673 | |
| FTRPQAEISFCPHDA | 271 | Q9BRG2 | |
| RPAFPAFSFRGCHSA | 176 | Q8N7X2 | |
| FTAETHNFPTGVCPF | 306 | O15067 | |
| AAHIFFTDTCPEPLF | 101 | Q15833 | |
| PRAADFLFSCDASHP | 31 | Q8NHR7 | |
| SQARFSACLPPSSHD | 206 | A8MQ27 | |
| CHVFRATDPSQVPDV | 156 | O60343 | |
| EVPSFQPRLFECSSH | 606 | O15195 | |
| HRCFQEPPSSFTSTN | 181 | Q96JG9 | |
| CSATSTFNFHPNVRP | 1506 | O75643 | |
| VAEPPVICSHFAQDF | 71 | Q96N22 | |
| CFRLPENITHAFPSS | 251 | Q658N2 | |
| LFSHQPFPRGCSASE | 201 | Q8N228 | |
| AAPFRCEFDSQASAP | 216 | O43542 | |
| CIPEENNSAHPSFFS | 1316 | Q8WXR4 |